O tratamento contínuo superior a cinco anos com ácido ursodesoxicólico gera benefícios na taxa de mortalidade e na taxa de transplantes em colangite biliar primária: revisão sistemática da literatura e metanálise

Júnior, Argemiro D'Oliveira; Menezes, Larissa Pires; Fahham, Lucas de Vasconcelos; Fernandes, Roberta Arinelli; Teich, Vanessa.
J. bras. econ. saúde (Impr.) ; 10(1): 45-55, Abr. 2018.
Artigo em Português | LILACS, ECOS | ID: biblio-884394

Documentos relacionados

  1. Mycobacterium tuberculosis latent infection in healthcare students: systematic review of prevalence
  2. Clinical outcomes and sick leave in relation to UDCA treatment in Swedish patients with primary biliary cholangitis.
  3. Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.
  4. Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis.
  5. Prevalência de tuberculose na população privada de liberdade: revisão sistemática e metanálise
  6. Colangitis biliar primaria: caracterización de una cohorte retrospectiva
  7. [Primary biliary cholangitis-established and novel therapies].
  8. Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis.
  9. Efetividade de protocolos de dor torácica para alta precoce e segura de adultos com sintomas sugestivos de síndrome coronariana aguda: revisão sistemática e metanálise
  10. High neutrophil-lymphocyte ratio indicates a worse response to ursodeoxycholic acid in primary biliary cholangitis: a retrospective cohort study.